Conor's DES (drug-eluting stent) shows promise, deals struck with Biotronik
This article was originally published in Clinica
Executive Summary
Conor Medsystems is steaming ahead with plans to enter the drug-eluting stent (DES) sector with a new type of technology designed to overcome certain limitations in the engineering and drug delivery of existing methods.